Valeant goes hostile, to launch Allergan exchange offer this week: Reuters
Valeant Pharmaceuticals Inc said on Tuesday it will launch an exchange offer for Allergan Inc this week, allowing it to eventually take the unsolicited bid directly to shareholders, Reuters reported. Botox-maker Allergan has rejected Valeant’s offer of cash and shares. Additionally, Allergan's biggest shareholder, Pershing Square Capital Management, intends to mail proxy materials to seek a special meeting later this year to change most of Allergan’s board, Valeant said.
17 June 2014•3 mins read
